Search - tctmd.com

Displaying 161 - 180 of 2055

Sort: Relevancy | Date

News Daily News

Can’t Exercise for a Cardiac Stress Test? That’s a Bad Sign

Todd Neale

February 25, 2025

News Daily News

Invasive Testing Safely Diagnoses Microvascular Dysfunction in ANOCA

Michael O'Riordan

February 24, 2025

News Daily News

‘Arbitrary’ Hodgepodge of Composite Endpoints Used Across ASCVD Trials

Michael O'Riordan

February 20, 2025

News Daily News

Aortic Stenosis Slowed by SGLT2 Inhibitors in Observational Study

Yael L. Maxwell

February 20, 2025

News Daily News

More Excess Bleeding Seen With Rivaroxaban vs Other NOACs and Aspirin

L.A. McKeown

February 14, 2025

News Daily News

Olpasiran Cuts Lp(a) but Not Inflammatory Markers: OCEAN(a)-DOSE

Yael L. Maxwell

February 14, 2025

News Daily News

AHA Scientific Statement Takes Aim at PAD Pain

L.A. McKeown

February 13, 2025

News Daily News

Even on Tafamidis, ATTR-CM Patients Face High Mortality Over Time

Michael O'Riordan

February 13, 2025

News Conference News THT 2025

Tirzepatide Helps in HFpEF Across Spectrum of Obesity Severity

Todd Neale

February 12, 2025

News Daily News

Elderly ASCVD Patients Benefit From Aggressive LDL-Lowering With Evolocumab

Michael O'Riordan

February 05, 2025

News Daily News

Use of Secondary CVD Prevention Meds Still Meager Worldwide

Caitlin E. Cox

February 03, 2025

News Opinion CV Team Dispatch

February 2025 Dispatch for the CV Team

L.A. McKeown

February 01, 2025

News Daily News

Cardiometabolic Trends Dominate First Round of Drugs Chosen for Medicare Price Negotiations

L.A. McKeown

January 31, 2025

News Opinion CV Team Dispatch

January 2025 Dispatch for the CV Team

L.A. McKeown

January 24, 2025

News Daily News

Aspirin Use for Primary Prevention Declining in US: NHANES

Michael O'Riordan

January 24, 2025

News Daily News

Benefits of Various SGLT2 Inhibitors Mostly Consistent in Observational Study

Michael O'Riordan

January 22, 2025

News Daily News

European Medicines Agency Investigating GLP-1 Drugs and Eye Disease

L.A. McKeown

January 21, 2025

News Daily News

Misleading Statements Common in Online Ads for Compounded GLP-1s

L.A. McKeown

January 20, 2025

News Daily News

Athletes’ Hearts Also Require Careful Scrutiny, New Review Suggests

Yael L. Maxwell

January 17, 2025

News Features

Weight-Loss Showdown: Is It Time for an RCT of Bariatric Surgery vs GLP-1s?

Michael O'Riordan

January 17, 2025

Advertisement

Can’t Exercise for a Cardiac Stress Test? That’s a Bad Sign

Invasive Testing Safely Diagnoses Microvascular Dysfunction in ANOCA

‘Arbitrary’ Hodgepodge of Composite Endpoints Used Across ASCVD Trials

Aortic Stenosis Slowed by SGLT2 Inhibitors in Observational Study

More Excess Bleeding Seen With Rivaroxaban vs Other NOACs and Aspirin

Olpasiran Cuts Lp(a) but Not Inflammatory Markers: OCEAN(a)-DOSE

AHA Scientific Statement Takes Aim at PAD Pain

Even on Tafamidis, ATTR-CM Patients Face High Mortality Over Time

Tirzepatide Helps in HFpEF Across Spectrum of Obesity Severity

Elderly ASCVD Patients Benefit From Aggressive LDL-Lowering With Evolocumab

Use of Secondary CVD Prevention Meds Still Meager Worldwide

February 2025 Dispatch for the CV Team

Cardiometabolic Trends Dominate First Round of Drugs Chosen for Medicare Price Negotiations

January 2025 Dispatch for the CV Team

Aspirin Use for Primary Prevention Declining in US: NHANES

Benefits of Various SGLT2 Inhibitors Mostly Consistent in Observational Study

European Medicines Agency Investigating GLP-1 Drugs and Eye Disease

Misleading Statements Common in Online Ads for Compounded GLP-1s

Athletes’ Hearts Also Require Careful Scrutiny, New Review Suggests

Weight-Loss Showdown: Is It Time for an RCT of Bariatric Surgery vs GLP-1s?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content